Skip to content
Skip to navigation
Skip to footer

Archive

View global media contacts

Home / Media Centre / Archive

Here you can find the archive of all Press Releases prior to 2023

Filter by date:

Showing 1239 press releases before 2023

US and EU regulatory submissions for VANDETANIB in advanced medullary thyroid cancer accepted for review
23 September 2010
24-Week Phase 3 Study Found Investigational Drug Dapagliflozin Improved Glycosylated Hemoglobin (HbA1c) When Added to Glimepiride in Adults with Type 2 Diabetes Mellitus
20 September 2010
US Food and Drug Administration Extends Review Timeline For BRILINTA (Ticagrelor) New Drug Application
15 September 2010
European Commission Issues Positive Decision for Approval of Seroquel XR as an Add-On Treatment of Major Depressive Disorder
2 September 2010
MedImmune receives complete response letter on motavizumab
30 August 2010
Genetic substudy shows fewer major cardiovascular events with ticagrelor (brilinta) regardless of relevant genetic variability in ACS patients
29 August 2010
AstraZeneca Announces Agreements in Principle in Seroquel Product Liability Litigation
9 August 2010
FDA Advisory Committee recommends US FDA approval of Brilinta (ticagrelor) for Acute Coronary Syndromes
29 July 2010
AstraZeneca Second Quarter and Half Year Results 2010
29 July 2010
AstraZeneca PLC Appoints New Non-Executive Director
29 July 2010

<
1
2
3
124
>

All of our latest press releases and articles are available to explore